Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial-Reference-Cited by-同舟云学术

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial

Published:2016-03 Issue: Volume:173 Page:94-101
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Sabatine Marc S.,Giugliano Robert P.,Keech Anthony,Honarpour Narimon,Wang Huei,Liu Thomas,Wasserman Scott M.,Scott Robert,Sever Peter S.,Pedersen Terje R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. World health statistics 2015;World Health Organization,2015

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Cholesterol Treatment Trialists C;Lancet,2010

3. Clofibrate and niacin in coronary heart disease;Coronary Drug Project Research Group;JAMA,1975

4. The lipid research clinics coronary primary prevention trial results;Lipid Research Clinics Program;JAMA,1984

5. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia;Frick;N Engl J Med,1987

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dyslipoproteinemias in postmenopausal women and new therapeutic targets;Obstetrics & Gynecology International Journal;2024-08-28

2. Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions;Biomedicines;2024-07-26

3. Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan;World Journal of Cardiology;2024-05-26

4. PCSK9i promoting the transformation of AS plaques into a stable plaque by targeting the miR-186-5p/Wipf2 and miR-375-3p/Pdk1/Yap1 in ApoE−/− mice;Frontiers in Medicine;2024-02-26

5. Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease;Journal of the American College of Cardiology;2024-02